Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Blinatumomab Bridging Therapy for BALL
Phase 2
Terminated
- Conditions
- B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Michael Burke
- Target Recruit Count
- 2
- Registration Number
- NCT04556084
- Locations
- 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Epigenetic Reprogramming in Relapse AML
Phase 1
Terminated
- Conditions
- Leukemia, Acute Myeloid
- Interventions
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- Michael Burke
- Target Recruit Count
- 3
- Registration Number
- NCT02412475
- Locations
- 🇺🇸
Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
News
No news found